Effect of age and cancer on peripheral immune cell subsets and their PD-1 and PD-L1 expression

Eitemau Tebyg

• PD-1 and PD-L1 expression on PBMC subsets in normal individuals and cancer patients
  gan: Lepone, Lauren, et al.
  Cyhoeddwyd: (2014)
• Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells
  gan: Lepone, Lauren, et al.
  Cyhoeddwyd: (2015)
• Analyses of 123 Peripheral Human Immune Cell Subsets: Defining Differences with Age and between Healthy Donors and Cancer Patients Not Detected in Analysis of Standard Immune Cell Types
  gan: Lepone, Lauren M., et al.
  Cyhoeddwyd: (2016)
• Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody
  gan: Donahue, Renee N., et al.
  Cyhoeddwyd: (2017)
• Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses
  gan: Heery, Christopher R, et al.
  Cyhoeddwyd: (2015)